Viking Therapeutics Stock In The News
| VKTX Stock | USD 30.89 1.16 3.90% |
Our overall analysis of Viking Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Viking Therapeutics. The specific impact of Viking Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Viking Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Viking Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Viking Therapeutics Backtesting and Viking Therapeutics Hype Analysis. For more information on how to buy Viking Stock please use our How to Invest in Viking Therapeutics guide.
Viking |
Viking Therapeutics Today Top News and Investor Outlook
Viking Therapeutics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Viking and other traded companies coverage with news coverage. We help investors stay connected with Viking headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Viking Stock performance. Please note that trading solely based on the Viking Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Viking Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Viking earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Viking Therapeutics that are available to investors today. That information is available publicly through Viking media outlets and privately through word of mouth or via Viking internal channels. However, regardless of the origin, that massive amount of Viking data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Viking Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Viking Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Viking Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Viking Therapeutics alpha.
Viking Largest EPS Surprises
Earnings surprises can significantly impact Viking Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-04-27 | 2022-03-31 | -0.19 | -0.21 | -0.02 | 10 | ||
2021-04-28 | 2021-03-31 | -0.17 | -0.19 | -0.02 | 11 | ||
2020-10-28 | 2020-09-30 | -0.15 | -0.13 | 0.02 | 13 | ||
2019-08-01 | 2019-06-30 | -0.09 | -0.11 | -0.02 | 22 | ||
2019-05-02 | 2019-03-31 | -0.09 | -0.07 | 0.02 | 22 | ||
2018-08-09 | 2018-06-30 | -0.11 | -0.13 | -0.02 | 18 |
Viking Therapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Viking Therapeutics Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
13th of March 2025
NVO Stock Slips 4 percent as Roche Inks Obesity Drug Deal With Zealand at zacks.com
11th of March 2025
Wall Street Bulls Look Optimistic About Viking Therapeutics Should You Buy at zacks.com
10th of March 2025
Novo Nordisks Ozempic successor disappointed Wall Street again at finance.yahoo.com
7th of March 2025
Viking Therapeutics, Inc. Beats Stock Market Upswing What Investors Need to Know at zacks.com
6th of March 2025
Viking Therapeutics Stock Price Up 7.8 percent Still a Buy at thelincolnianonline.com
4th of March 2025
Viking Therapeutics Inc Announces Participation in Upcoming Investor Conferences at gurufocus.com
3rd of March 2025
AbbVie Enters The Obesity Arena. Why Its Paying Up To 2.23 Billion. at investors.com
28th of February 2025
1 Biotech Stock to Buy in 2025, and 1 to Avoid at finance.yahoo.com
27th of February 2025
Prediction Novo Nordisk Will Soar Over the Next 5 Years. Heres 1 Reason Why. at finance.yahoo.com
26th of February 2025
Is Viking Therapeutics a Buy Right Now at finance.yahoo.com
20th of February 2025
Why Viking Therapeutics, Inc. Went Up On Wednesday at finance.yahoo.com
6th of February 2025
Viking Therapeutics Reports Q4 2024 Financial Results, Advances VK2735 Trials at gurufocus.com
31st of January 2025
Jim Cramer Says I Want You To Sell Viking Therapeutics, Inc. And Roll It Into Viking Holdi... at news.google.com
Viking Therapeutics Investors Sentiment
The influence of Viking Therapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Viking. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Viking Therapeutics' public news can be used to forecast risks associated with an investment in Viking. The trend in average sentiment can be used to explain how an investor holding Viking can time the market purely based on public headlines and social activities around Viking Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Viking Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Viking Therapeutics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Viking Therapeutics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Viking Therapeutics.
Viking Therapeutics Implied Volatility | 1.26 |
Viking Therapeutics' implied volatility exposes the market's sentiment of Viking Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Viking Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Viking Therapeutics stock will not fluctuate a lot when Viking Therapeutics' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Viking Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Viking Therapeutics' short interest history, or implied volatility extrapolated from Viking Therapeutics options trading.
Additional Tools for Viking Stock Analysis
When running Viking Therapeutics' price analysis, check to measure Viking Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viking Therapeutics is operating at the current time. Most of Viking Therapeutics' value examination focuses on studying past and present price action to predict the probability of Viking Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viking Therapeutics' price. Additionally, you may evaluate how the addition of Viking Therapeutics to your portfolios can decrease your overall portfolio volatility.